作者：
Fanale,M. [1]
;
Assouline,S. [2]
;
Kuruvilla,J. [3]
;
Solal-Céligny,P. [4]
;
Heo,D.S. [5]
;
Verhoef,G. [6]
;
Corradini,P. [7]
;
Abramson,J.S. [8]
;
Offner,F. [9]
;
Engert,A. [10]
;
Dyer,M.J.S. [11]
;
Carreon,D. [12]
;
Ewald,B. [13]
;
Baeck,J. [14]
;
Younes,A. ;
Freedman,A.S.
作者单位：
Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States
[1]
Department of Cancer Studies and Molecular Medicine, University of Leicester, Leicester, United
[2]
Department of Haematology, University Hospital of Leuven, Leuven, Belgium
[3]
Department of Haematology, Ghent University Hospital, Ghent, Belgium
[4]
Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA, United States
[5]
Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, ON, Canada
[6]
IRCCS National Cancer Institute, University of Milan, Milan, Italy
[7]
Institut de Cancérologie de l'Ouest, Nantes, France
[8]
University of Texas MD Anderson Cancer Center, Houston, TX, United States
[9]
University Hospital of Cologne, Cologne, Germany
[10]
Dana-Farber Cancer Institute, Boston, MA, United States
[11]
Jewish General Hospital, McGill University, Montreal, QC, Canada
[12]
Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea
[13]
Memorial Sloan-Kettering Cancer Center, New York, NY, United States
[14]
发布时间
2014-03-08
换一批
